{{Rsnum
|rsid=4353
|Gene=ACE
|Chromosome=17
|position=63493061
|Orientation=plus
|GMAF=0.4982
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ACE
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 27.0 | 46.8 | 26.1
| HCB | 11.0 | 43.4 | 45.6
| JPT | 19.6 | 55.4 | 25.0
| YRI | 40.8 | 46.3 | 12.9
| ASW | 33.3 | 59.6 | 7.0
| CHB | 11.0 | 43.4 | 45.6
| CHD | 15.7 | 50.9 | 33.3
| GIH | 17.8 | 46.5 | 35.6
| LWK | 34.5 | 47.3 | 18.2
| MEX | 24.1 | 34.5 | 41.4
| MKK | 42.9 | 46.2 | 10.9
| TSI | 42.6 | 43.6 | 13.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=21261619
|Title=Genetic variation in renin predicts the effects of thiazide diuretics
}}

{{PMID|12975525|OA=1
}} Single-nucleotide polymorphism genotyping on optical thin-film biosensor chips.

{{PMID|18076107|OA=1
}} Confronting complexity in late-onset Alzheimer disease: application of two-stage analysis approach addressing heterogeneity and epistasis.

{{PMID|19001172|OA=1
}} Analyses of the National Institute on Aging Late-Onset Alzheimer's Disease Family Study: implication of additional loci.

{{PMID|19105203|OA=1
}} An association analysis of Alzheimer disease candidate genes detects an ancestral risk haplotype clade in ACE and putative multilocus association between ACE, A2M, and LRRTM3.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}